Biological E Seeks DCGI’s Nod for Phase-3 Trial of Corbevax as Booster Dose in Those Vaccinated with Covishield or Covaxin

The DCGI in September also granted permission to the Biological E to conduct phase 2/3 clinical trials of the vaccine in children aged between 5 and 18 years with certain conditions.

Source: Top India News- News18.com